Hhlr Advisors, Ltd. Immunocore Holdings PLC Transaction History

Hhlr Advisors, Ltd.

  • $4.36 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$18.94 - $34.29 $5.26 Million - $9.52 Million
-277,754 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$32.22 - $41.5 $58,833 - $75,779
-1,826 Reduced 0.65%
277,754 $10.8 Million
Q1 2021

May 17, 2021
BUY
$36.3 - $56.34 $10.1 Million - $15.8 Million
279,580 New
279,580 $11.9 Million

Others Institutions Holding IMCR

# of Institutions
135
Shares Held
41.3M
Call Options Held
197K
Put Options Held
451K
View Full List

About Immunocore Holdings plc

IMCR Quotes by TradingView
  • Ticker IMCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,897,100
  • Market Cap $1.44B
  • Description
  • Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...
More about IMCR
Track This Portfolio

Track Hhlr Advisors, Ltd. Portfolio

Follow Hhlr Advisors, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hhlr Advisors, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Hhlr Advisors, Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email